Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Adlea studied in new phase II trial in arthroscopic shoulder surgery

July 18, 2008

Sigma-1 receptors, therapeutic targets in neuropsychiatric diseases

July 18, 2008

Enrollment completed in phase I study of Alzheimer's vaccine Affitope AD-01

July 17, 2008

Enrollment under way in phase III laquinimod study in RRMS

July 17, 2008

Recent patents disclose new compounds for sleep disorders, anxiety disorders and schizophrenia

July 17, 2008

Alzheimer's drug candidate MCD-386 begins phase I trial

July 17, 2008

Preclinical studies at Karo Bio support the use of ERbeta agonists in treating depression

July 17, 2008

Recent Dainippon Sumitomo patent describes new analgesic agents

July 17, 2008

JN-403, a novel alpha7 nAch receptor profiled at Novartis

July 17, 2008

ABT-925 demonstrates regionally selective dopamine D3 occupancy in humans

July 17, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 21, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...